Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial. (Q45221374)
Jump to navigation
Jump to search
scientific article published on 17 March 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial. |
scientific article published on 17 March 2014 |
Statements
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial (English)
John M M Raemaekers
Marc P E André
Theodore Girinsky
Reman Oumedaly
Ercole Brusamolino
Pauline Brice
Christophe Fermé
Richard van der Maazen
Manuel Gotti
Reda Bouabdallah
Catherine J Sebban
Yolande Lievens
Allessandro Re
Aspasia Stamatoullas
Frank Morschhauser
Pieternella J Lugtenburg
Pierre Olivier
Gustaaf van Imhoff
Tiana Raveloarivahy
Monica Bellei
Thierry van der Borght
Stephane Bardet
Annibale Versari
Michel Meignan
Catherine Fortpied